Introduction
In recent years, India has witnessed a significant surge in its diabetic population, prompting a corresponding rise in demand for diabetes care products and services. According to the latest TechSci Research report titled “India Diabetes Care Market By Type of Product (Diabetes Drug and Diabetic Devices), By Diabetes Type (Type 1, Type 2 and Gestational Diabetes), By End-User (Hospital, Homeclinic, Homecare) By Region, Competition, Forecast & Opportunities, 2028,” the country’s diabetes care market is projected to grow robustly at a compound annual growth rate (CAGR) of 7.94%.
Recent Trends in India’s Diabetes Care Market
The escalating urbanization, coupled with the adoption of sedentary lifestyles and increased disposable incomes, has fueled the prevalence of diabetes in India. This demographic shift has propelled the demand for diabetes care products and services across the nation. Moreover, advancements in medical technology and the introduction of innovative continuous glucose monitoring devices tailored for various types of diabetes, including type 1, type 2, and gestational diabetes, have further augmented the growth of the diabetes care market in India.
Browse 20 Figures spread through 70 Pages and an in-depth TOC on “India Diabetes Care Market“.
https://www.techsciresearch.com/report/india-diabetes-care-market/7253.html
Understanding the Market Dynamics
The India diabetes care market is broadly categorized into two segments: diabetes drugs and diabetic devices. Historically, the drug segment has dominated the market, accounting for the lion’s share of the revenue. However, the diabetic devices segment is witnessing rapid growth in value terms, attributed to its ease of use and continuous innovation. By the end of the forecast period in FY2028, the value share of device-based diabetes care is anticipated to increase to 47.18%. This growth trajectory is underpinned by the continuous launch of user-friendly devices and the rising purchasing power of consumers.
Competitive Landscape
A plethora of companies are actively participating in India’s diabetes care market, striving to capture a larger market share and establish themselves as key players. Some prominent names in this space include Novo Nordisk India Private Limited, Sanofi India Limited, Eli Lilly India Pvt. Ltd., Roche Diagnostics India Pvt Ltd., Abbott India Limited, Becton Dickinson Private Limited, Johnson & Johnson Private Limited, India Medtronic Pvt. Ltd., Ypsomed India Private Ltd., and Novartis India Ltd.
Benefits of the Research Report
The TechSci Research report on the India diabetes care market offers invaluable insights and strategic recommendations for stakeholders, including:
- Market Growth Forecast: Provides a comprehensive analysis of the market dynamics, including historical data and future projections, aiding stakeholders in making informed decisions.
- Segmentation Analysis: Offers a detailed segmentation of the market based on product type, diabetes type, end-user, and region, enabling companies to tailor their strategies according to specific market segments.
- Competitive Intelligence: Presents a thorough analysis of the competitive landscape, including the profiles of key players, their market strategies, and recent developments, assisting companies in devising effective competitive strategies.
- Trend Analysis: Identifies and analyzes recent trends and developments in the diabetes care market, helping companies stay abreast of market dynamics and capitalize on emerging opportunities.
- Market Entry Strategies: Provides insights into potential entry barriers, regulatory frameworks, and investment opportunities, enabling new entrants to devise successful market entry strategies.
- Customer Insights: Offers valuable insights into consumer preferences, buying behavior, and unmet needs, empowering companies to develop products and services that resonate with target customers.
- Risk Assessment: Assesses potential risks and challenges associated with market entry and expansion, facilitating risk mitigation and contingency planning for companies.
- Investment Opportunities: Highlights lucrative investment opportunities in the diabetes care market, including emerging trends, innovative technologies, and untapped market segments.
- Regulatory Compliance: Provides an overview of regulatory requirements and compliance standards governing the diabetes care market, ensuring companies adhere to applicable regulations and standards.
- Strategic Recommendations: Offers strategic recommendations and actionable insights to help companies enhance their market position, optimize their product portfolio, and capitalize on growth opportunities effectively.
The TechSci Research report on India’s diabetes care market provides a comprehensive analysis of the market landscape, including recent trends, competitive dynamics, and growth prospects. With invaluable insights and strategic recommendations, the report serves as a vital tool for companies seeking to capitalize on the lucrative opportunities offered by India’s burgeoning diabetes care market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7253
Customers can also request for 10% free customization on this report.
“Diabetes care market in India includes several players, including a blend of large multi-nationals as well as small players forming a large unorganized market. Multinational companies such as Abbott India Limited, Sanofi India Limited, Eli Lilly India Pvt, Novo Nordisk India Private Limited, etc., have either set up their production facilities in India or implement contract manufacturing processes, to grab the opportunity of booming diabetes care market and increase of their product portfolio as per consumers drug requirements which is expected to drive the growth of organized sector in the coming years. Also, guidelines related to manufacturing and marketing of diabetes care as per Indian and International standards have been implemented which is primarily focused on the development of newer products, exploitation of technology and enhancement of distribution network. This is expected to give a boost in the country’s Diabetes Care market in the coming years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“India Diabetes Care Market By Type of Product (Diabetes Drug and Diabetic Devices), By Diabetes Type (Type 1, Type 2 and Gestational Diabetes), By End-User (Hospital, Homeclinic, Homecare) By Region, Competition, Forecast & Opportunities, 2028” has evaluated the future growth potential of India diabetes care market and provided statistics and information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India diabetes care market.
Table Of Content:
- Product of Interest Introduction: Diabetes Care Market
- Research Methodology
- Impact of COVID-19 on India Diabetes Care Market
- Executive Summary
- Voice of Customers/Customer Insights
- India Diabetes Care Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Diabetes Drugs vs. Diabetes Care Devices)
6.2.2. By Type of Diabetes (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
6.2.3. By End User (Home Care Settings, Hospitals, Clinics)
6.2.4. By Region (North, South, East, West)
6.2.5. By Company
6.3. Product Market Map
- India Diabetes Care Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices)
7.2.2. By Type of Diabetes
7.2.3. By End User
- India Diabetes Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Insulin, Dipeptidyl peptidase-4 (DPP-4) inhibitors, Glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists), Others (Sodium-glucose co-transporter-2 (SGLT2) inhibitors, Biguanides, Sulfonylureas))
8.2.2. By Type of Diabetes
8.2.3. By End User
Most Demanding Reports –
India Healthcare Analytics Market
India Ultrasound System Market
Contact Techsci Research
US –
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Web: https://www.techsciresearch.com/
